{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T01:29:49Z","timestamp":1794274189486,"version":"4.9.0"},"reference-count":270,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.biopha.2018.05.009","type":"journal-article","created":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T23:58:12Z","timestamp":1525996692000},"page":"8-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":107,"special_numbering":"C","title":["Drug targets for resistant malaria: Historic to future perspectives"],"prefix":"10.1016","volume":"104","author":[{"given":"Sahil","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.R.","family":"Bhardwaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.N.","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2018.05.009_bib0005","series-title":"World Malaria Report","year":"2017"},{"key":"10.1016\/j.biopha.2018.05.009_bib0010","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.tmaid.2005.06.009","volume":"4","author":"Ashley","year":"2006","journal-title":"Travel Med. Infect. Dis."},{"key":"10.1016\/j.biopha.2018.05.009_bib0015","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S1473-3099(06)70655-7","article-title":"Malaria in adolescence: burden of disease, consequences and opportunities for intervention","volume":"6","author":"Lalloo","year":"2006","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.biopha.2018.05.009_bib0020","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1136\/bmj.330.7499.1044-d","article-title":"WHO combats counterfeit malaria drugs in Asia","volume":"330","author":"Parry","year":"2005","journal-title":"Br. Med. J."},{"issue":"12","key":"10.1016\/j.biopha.2018.05.009_bib0025","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.pt.2008.09.005","article-title":"Recent highlights in antimalarial drug resistance and chemotherapy","volume":"24","author":"David","year":"2008","journal-title":"Res. Trends Parasitol."},{"issue":"5","key":"10.1016\/j.biopha.2018.05.009_bib0030","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1586\/ecp.09.28","article-title":"Novel antimalarial drug targets, hope for new antimalarial drugs","volume":"2","author":"Alam","year":"2009","journal-title":"Expert Rev. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2018.05.009_bib0035","doi-asserted-by":"crossref","first-page":"e59968","DOI":"10.1371\/journal.pone.0059968","article-title":"New targets for drug discovery against malaria","volume":"8","author":"Santos","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2018.05.009_bib0040","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4103\/2229-5070.175081","article-title":"Antimalarial drug resistance: an overview","volume":"6","author":"Antony","year":"2016","journal-title":"Trop Parasitol."},{"key":"10.1016\/j.biopha.2018.05.009_bib0045","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4269\/ajtmh.15-0007","article-title":"Antimalarial drug resistance: literature review and activities and findings of the ICEMR network","volume":"93","author":"Cui","year":"2015","journal-title":"Am. J. Trop Med. Hyg."},{"issue":"12","key":"10.1016\/j.biopha.2018.05.009_bib0050","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1128\/AAC.43.12.2943","article-title":"The pfmdr1 gene is associated with a multidrug-resistance phenotype in Plasmodium falciparum from the western border of Thailand","volume":"43","author":"Price","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.biopha.2018.05.009_bib0055","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S1097-2765(05)00077-8","article-title":"Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance","volume":"6","author":"Fiddock","year":"2000","journal-title":"Mol. Cell."},{"issue":"2","key":"10.1016\/j.biopha.2018.05.009_bib0060","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0166-6851(99)00148-6","article-title":"Mutations in the cytochrome b gene of Plasmodium berghei conferring resistance to atovaquone","volume":"10","author":"Syafruddin","year":"1999","journal-title":"Mol. Biochem Parasitol."},{"issue":"6","key":"10.1016\/j.biopha.2018.05.009_bib0065","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S1368-7646(98)80014-9","article-title":"P. falciparum dihydrofolate reductase and dihydropteroate synthase mutations: epidemiology and role in clinical resistance to antifolate","volume":"1","author":"Plowe","year":"1998","journal-title":"Drug. Resist Update"},{"key":"10.1016\/j.biopha.2018.05.009_bib0070","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature12876","article-title":"A molecular marker of artemisinin-resistant Plasmodium falciparum malaria","volume":"505","author":"Ariey","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2018.05.009_bib0075","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S1473-3099(15)70032-0","article-title":"Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a crosssectional survey of the K13 molecular marker","volume":"15","author":"Tun","year":"2015","journal-title":"Lancet Infect. Dis."},{"issue":"1","key":"10.1016\/j.biopha.2018.05.009_bib0080","doi-asserted-by":"crossref","first-page":"e84555","DOI":"10.1371\/journal.pone.0084555","article-title":"How patients take malaria treatment: a systematic review of the literature on adherence to antimalarial drugs","volume":"9","author":"Bruxvoort","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2018.05.009_bib0085","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1073\/pnas.022630099","article-title":"Four plasmepsins are active in the P. falciparum food vacuole, including a protease with an active-site histidine","volume":"99","author":"Banerjee","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2018.05.009_bib0090","doi-asserted-by":"crossref","first-page":"29000","DOI":"10.1074\/jbc.M004459200","article-title":"Characterization of native and recombinant falcipain-2, a principal trophozoite cysteine protease and essential hemoglobinase of P. falciparum","volume":"275","author":"Shenai","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2018.05.009_bib0095","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1042\/bj3600481","article-title":"Expression and characterization of the P. falciparum haemoglobinase falcipain-3","volume":"360","author":"Sijwali","year":"2001","journal-title":"J. Biochem."},{"key":"10.1016\/j.biopha.2018.05.009_bib0100","doi-asserted-by":"crossref","first-page":"32411","DOI":"10.1074\/jbc.274.45.32411","article-title":"Identification and characterization of falcilysin, a metallopeptidase involved in hemoglobin catabolism within the malaria parasite P. falciparum","volume":"274","author":"Eggleson","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2018.05.009_bib0105","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0166-6851(01)00327-9","article-title":"The role of aminopeptidases in hemoglobin degradation in P. falciparum-infected erythrocytes","volume":"117","author":"Gavigan","year":"2001","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.biopha.2018.05.009_bib0110","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1128\/AAC.45.9.2577-2584.2001","article-title":"New class of small nonpeptidyl compounds blocks P. falciparum development in vitro by inhibiting plasmepsins","volume":"45","author":"Jiang","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2018.05.009_bib0115","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/978-1-4615-5373-1_56","article-title":"Studies on plasmepsins I and II from the malarial parasite P. falciparum and their exploitation as drug targets","volume":"436","author":"Moon","year":"1998","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.biopha.2018.05.009_bib0120","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/j.1460-2075.1994.tb06263.x","article-title":"Molecular characterization and inhibition of a P. falciparum aspartic hemoglobinase","volume":"13","author":"Francis","year":"1994","journal-title":"EMBO J."},{"key":"10.1016\/j.biopha.2018.05.009_bib0125","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1021\/jm980641t","article-title":"Potent, low-molecular-weight non-peptide inhibitors of malarial aspartyl protease plasmepsin II","volume":"42","author":"Haque","year":"1999","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2018.05.009_bib0130","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S1471-4922(01)02037-2","article-title":"Aspartic proteases of Plasmodium falciparum and other parasitic protozoa as drug targets","volume":"17","author":"Coombs","year":"2001","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.biopha.2018.05.009_bib0135","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2174\/156802612799362959","article-title":"Recent advances in plasmepsin medicinal chemistry and implications for future antimalarial drug discovery efforts","volume":"12","author":"Meyers","year":"2012","journal-title":"Curr. TopMed. Chem."},{"issue":"7281","key":"10.1016\/j.biopha.2018.05.009_bib0140","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nature08728","article-title":"An aspartyl protease directs malaria effector proteins to the host cell","volume":"463","author":"Boddey","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2018.05.009_bib0145","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/nature08726","article-title":"Plasmepsin V licenses Plasmodium proteins for export into the host erythrocyte","volume":"463","author":"Russo","year":"2010","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.biopha.2018.05.009_bib0150","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.bbrc.2009.01.083","article-title":"Plasmodium falciparum signal peptide peptidase is a promising drug target against blood stage malaria","volume":"380","author":"Li","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"52","key":"10.1016\/j.biopha.2018.05.009_bib0155","doi-asserted-by":"crossref","first-page":"21486","DOI":"10.1073\/pnas.1216016110","article-title":"Targeting the ERAD pathway via inhibition of signal peptide peptidase for antiparasitic therapeutic design","volume":"109","author":"Harbut","year":"2012","journal-title":"PNAS"},{"key":"10.1016\/j.biopha.2018.05.009_bib0160","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1128\/AAC.00840-06","article-title":"Synergistic interactions of the antiretroviral protease inhibitors saquinavir and ritonavir with chloroquine and mefloquine against Plasmodium falciparum in vitro","volume":"51","author":"Skinner-Adams","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2018.05.009_bib0165","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/infdis\/jit132","article-title":"HIV treatments have malaria gametocyte killing and transmission blocking activity","volume":"208","author":"Hobbs","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.biopha.2018.05.009_bib0170","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1128\/AAC.49.7.2983-2985.2005","article-title":"Antimalarial activity of human immunodeficiency virus type 1 protease inhibitor","volume":"49","author":"Parikh","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2018.05.009_bib0175","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ijantimicag.2017.04.006","article-title":"Targeting the active sites of malarial proteases for antimalarial drug discovery: approaches, progress and challenges","volume":"50","author":"Roy","year":"2017","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"12","key":"10.1016\/j.biopha.2018.05.009_bib0180","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1093\/infdis\/jiu346","article-title":"Lopinavir\/ritonavir-based antiretroviral treatment (art) versus efavirenz-based art for the prevention of malaria among hiv-infected pregnant women","volume":"210","author":"Natureeba","year":"2012","journal-title":"J. Inf. Dis."},{"key":"10.1016\/j.biopha.2018.05.009_bib0185","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1042\/bj20020793","article-title":"Fate of haem iron in the malaria parasite Plasmodium falciparum","volume":"365","author":"Egan","year":"2012","journal-title":"Biochem. J."},{"key":"10.1016\/j.biopha.2018.05.009_bib0190","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1016\/j.bbagen.2014.02.009","article-title":"Malaria hemozoin: from target to tool","volume":"1840","author":"Coronado","year":"2014","journal-title":"Biochem. Biophys. Acta"},{"key":"10.1016\/j.biopha.2018.05.009_bib0195","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.4155\/fmc.13.113","article-title":"Hemozoin and antimalarial drug discovery","volume":"5","author":"Fong","year":"2013","journal-title":"Fut. Med. Chem."},{"key":"10.1016\/j.biopha.2018.05.009_bib0200","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1146\/annurev-micro-091313-103537","article-title":"The peculiarities and paradoxes of Plasmodium heme metabolism","volume":"68","author":"Sigala","year":"2014","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.biopha.2018.05.009_bib0205","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35005132","article-title":"The structure of malaria pigment \u03b2-haematin","volume":"404","author":"Pagola","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2018.05.009_bib0210","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1128\/AAC.42.11.2973","volume":"42","author":"Mungthin","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"10.1016\/j.biopha.2018.05.009_bib0215","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1371\/journal.pntd.0000477","article-title":"Interference with hemozoin formation represents an important mechanism of schistosomicidal action of antimalarial quinoline methanols","volume":"3","author":"Correa Soares","year":"2009","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"6","key":"10.1016\/j.biopha.2018.05.009_bib0220","doi-asserted-by":"crossref","first-page":"4946","DOI":"10.1073\/pnas.1501023112","article-title":"Mechanism of hematin crystallization and inhibition by the antimalarial drug chloroquine","volume":"112","author":"Olafsona","year":"2015","journal-title":"PNAS"},{"key":"10.1016\/j.biopha.2018.05.009_bib0225","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10111","article-title":"Haeme-activated promiscuous targeting of artemisinin in Plasmodium falciparum","author":"Wang","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2018.05.009_bib0230","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1042\/BJ20060986","article-title":"The role of neutral lipid nanospheres in plasmodium falciparum heme crystallization","volume":"402","author":"Pisciotta","year":"2007","journal-title":"Biochem. J."},{"key":"10.1016\/j.biopha.2018.05.009_bib0235","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.bioorg.2016.11.010","article-title":"Antimalarial activity of novel 4-aminoquinolines active against drug resistant strains","volume":"70","author":"Kondaparla","year":"2017","journal-title":"Biorg. Chem."},{"key":"10.1016\/j.biopha.2018.05.009_bib0240","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1016\/j.bmcl.2010.09.123","article-title":"A single, low, oral dose of a 5-carbon-linked trioxane dimer orthoester plus mefloquine cures malaria-infected mice","volume":"21","author":"Moon","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2018.05.009_bib0245","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1021\/jm901473s","article-title":"The structure-activity relationship of the antimalarial ozonide arterolane","volume":"53","author":"Dong","year":"2010","journal-title":"Med. Chem."},{"key":"10.1016\/j.biopha.2018.05.009_bib0250","doi-asserted-by":"crossref","first-page":"4400","DOI":"10.1073\/pnas.1015762108","article-title":"Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria","volume":"108","author":"Charman","year":"2011","journal-title":"PNAS"},{"key":"10.1016\/j.biopha.2018.05.009_bib0255","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1021\/ol8023874","article-title":"Broadly applicable synthesis of 1,2,4,5-Tetraoxanes","volume":"11","author":"Ghorai","year":"2009","journal-title":"Org. Lett."},{"key":"10.1016\/j.biopha.2018.05.009_bib0260","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1055\/s-0032-1306317","article-title":"Intersex effect of lamotrigine on the pharmacokinetic parameters of cdri-97\/78, a novel trioxane antimalarial compound, in rats","volume":"62","author":"Kushwaha","year":"2012","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.biopha.2018.05.009_bib0265","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0166-6851(97)00062-5","article-title":"Generation of hemoglobin peptidases in the acidic digestive vacuole of P. falciparum implicates peptide transport in amino acid production","volume":"87","author":"Kolakovich","year":"1997","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.biopha.2018.05.009_bib0270","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nrm1552","article-title":"Proteolysis: from the lysosome to ubiquitin and the proteasome","volume":"6","author":"Ciechanover","year":"2005","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"10.1016\/j.biopha.2018.05.009_bib0275","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.tcb.2010.03.007","article-title":"Assembly structure and function of the 26S proteasome","volume":"20","author":"Bedford","year":"2010","journal-title":"Trends Cell. Biol."},{"key":"10.1016\/j.biopha.2018.05.009_bib0280","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.chembiol.2012.09.019","article-title":"Validation of the proteasome as a therapeutic target in Plasmodium using an epoxyketone inhibitor with parasite-specific toxicity","volume":"19","author":"Li","year":"2012","journal-title":"Chem. Biol."},{"key":"10.1016\/j.biopha.2018.05.009_bib0285","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0166-6851(97)00197-7","article-title":"Inhibition of proteasome activity blocks cell cycle progression at specific phase boundaries in African trypanosomes","volume":"90","author":"Mutomba","year":"1997","journal-title":"Mol. Biochem. Parasitol."},{"issue":"8","key":"10.1016\/j.biopha.2018.05.009_bib0290","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S1074-5521(01)00056-4","article-title":"Proteasome inhibitors: from research tools to drug candidates","author":"Kisselev","year":"2001","journal-title":"Chem. Bio"},{"key":"10.1016\/j.biopha.2018.05.009_bib0295","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1517\/14728222.2011.555399","article-title":"Threonine peptidases as drug targets against malaria","volume":"15","author":"Tschan","year":"2011","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.biopha.2018.05.009_bib0300","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1017\/S003118200500747X","article-title":"The proteasome inhibitor MLN-273 blocks exoerythrocytic and erythrocytic development of Plasmodium parasites","volume":"131","author":"Lindenthal","year":"2005","journal-title":"Parasitology"},{"key":"10.1016\/j.biopha.2018.05.009_bib0305","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/1475-2875-7-187","article-title":"Comprehensive study of proteasome inhibitors against Plasmodium falciparum laboratory strains and field isolates","volume":"7","author":"Kreidenweiss","year":"2008","journal-title":"Malar. J."},{"key":"10.1016\/j.biopha.2018.05.009_bib0310","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.1128\/AAC.00088-09","article-title":"The proteasome inhibitor epoxomicin has potent Plasmodium falciparum gametocytocidal activity","volume":"53","author":"Czesny","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"issue":"42","key":"10.1016\/j.biopha.2018.05.009_bib0315","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1128\/AAC.42.10.2731","article-title":"Proteasome inhibitors block development of Plasmodiumsp","author":"Gantt","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1824","key":"10.1016\/j.biopha.2018.05.009_bib0320","first-page":"177","article-title":"Proteases as regulators of pathogenesis: examples from the Apicomplexa","author":"Li","year":"2012","journal-title":"Biochem. Biophys Acta"},{"key":"10.1016\/j.biopha.2018.05.009_bib0325","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1098\/rstb.2009.0273","article-title":"The evolution, metabolism and functions of the apicoplast","volume":"365","author":"Lim","year":"2010","journal-title":"Phil. Trans. R. Soc. B : Biol. Sci."},{"key":"10.1016\/j.biopha.2018.05.009_bib0330","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/j.febslet.2011.05.002","article-title":"Functional genetics in Apicomplexa: potentials and limits","volume":"585","author":"Limenitakis","year":"2011","journal-title":"FEBS Lett."},{"key":"10.1016\/j.biopha.2018.05.009_bib0335","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1098\/rstb.2001.1047","article-title":"Mining the Plasmodium genome database to define organellar function: what does the apicoplast do?","volume":"357","author":"Roos","year":"2002","journal-title":"Philos. Trans. R. Soc. Lond. B: Biol. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2018.05.009_bib0340","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1054\/drup.2001.0205","article-title":"The apicoplast as an antimalarial drug target","author":"Ralph","year":"2001","journal-title":"Drug. Resist. Update"},{"key":"10.1016\/j.biopha.2018.05.009_bib0345","first-page":"677","article-title":"The algal past and parasite present of the apicoplast","author":"Van Dooren","year":"2013","journal-title":"Annu. Rev. Microbiol."},{"issue":"5","key":"10.1016\/j.biopha.2018.05.009_bib0350","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11101-005-5297-0","article-title":"Type II fatty acid biosynthesis, a new approach in antimalarial natural product discovery","author":"Tasdemir","year":"2006","journal-title":"Phytochem. Rev."},{"key":"10.1016\/j.biopha.2018.05.009_bib0355","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0163-7827(01)00012-1","article-title":"Lipid biosynthesis as a target for antibacterial agents","volume":"40","author":"Heath","year":"2001","journal-title":"Prog. Lipid Res."},{"issue":"8","key":"10.1016\/j.biopha.2018.05.009_bib0360","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/1386207053328192","article-title":"Fatty acid synthesis as a target for antimalarial drug discovery","author":"Lu","year":"2005","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"10.1016\/j.biopha.2018.05.009_bib0365","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.pt.2016.10.002","article-title":"Is it Mitochondrion a good malaria drug target?","volume":"33","author":"Goodman","year":"2017","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.biopha.2018.05.009_bib0370","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.molbiopara.2012.09.008","article-title":"Apicoplast triose phosphate transporter (TPT) gene knockoutis lethal for Plasmodium","volume":"186","author":"Banerjee","year":"2012","journal-title":"Mol. Biochem. Parasitol."},{"issue":"5","key":"10.1016\/j.biopha.2018.05.009_bib0375","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.tmaid.2006.01.015","article-title":"Plasmodium falciparum pyruvate kinase as a novel target for antimalarial drug-screening","author":"Chan","year":"2007","journal-title":"Travel Med. Inf. Dis."},{"key":"10.1016\/j.biopha.2018.05.009_bib0380","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.parint.2008.10.005","article-title":"Pyruvate kinase type-II isozyme in Plasmodium falciparum localizes to the apicoplast","volume":"58","author":"Maeda","year":"2009","journal-title":"Parasitol. Int."},{"issue":"23","key":"10.1016\/j.biopha.2018.05.009_bib0385","doi-asserted-by":"crossref","first-page":"21240","DOI":"10.1074\/jbc.M300339200","article-title":"Structural basis for flip-flop action of thiamin pyrophosphate-dependent enzymes revealed by human pyruvate dehydrogenase","volume":"278","author":"Ciszak","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2018.05.009_bib0390","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.molbiopara.2012.04.002","article-title":"Functional characterizations of malonyl-CoA acyl carrier protein transacylase (MCAT) in Eimeria tenella","volume":"184","author":"Sun","year":"2012","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.biopha.2018.05.009_bib0395","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/minf.201100051","article-title":"Deorphanization of malonyl CoA ACP transacylase drug target in Plasmodium falciparum (PfFabD) using bacterial antagonists: a \u2018Piggyback' approach for antimalarial drug discovery","volume":"31","author":"Sreshty","year":"2012","journal-title":"Mol. Inf."},{"key":"10.1016\/j.biopha.2018.05.009_bib0400","doi-asserted-by":"crossref","first-page":"6402","DOI":"10.1016\/j.bmcl.2008.10.097","article-title":"Synthesis and biological evaluation of novel sulfonyl-naphthalene-1,4-diols as FabH inhibitors","volume":"18","author":"Alhamadsheh","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2018.05.009_bib0405","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1021\/jm8008103","article-title":"Targeting the fatty acid biosynthesis enzyme Ketoacyl \u2212 Acylacyl carrier protein synthase III (PfKASIII), in the identification of novel antimalarial agents","volume":"52","author":"Lee","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2018.05.009_bib0410","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1110\/ps.062473707","article-title":"Structure of the human \u03b2-ketoacyl [ACP] synthase from the mitochondrial type II fatty acid synthase","volume":"16","author":"Christensen","year":"2007","journal-title":"Protein Sci."},{"key":"10.1016\/j.biopha.2018.05.009_bib0415","first-page":"281","article-title":"Recombinant expression and biochemical characterization of the unique elongating ketoacyl-acyl carrier protein synthase involved in fatty acid biosynthesis of plasmodium falciparum using natural and artificial substrates","author":"Lack","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2018.05.009_bib0420","doi-asserted-by":"crossref","first-page":"45661","DOI":"10.1074\/jbc.M304283200","article-title":"Identification, characterization and inhibition of Plasmodium falciparum \u03b2-hydroxy-acyl carrier protein dehydratase (Fab Z)","volume":"278","author":"Sharma","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2018.05.009_bib0425","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1042\/BJ20050832","article-title":"Kinetic inhibition and structural studies on 3-oxoacyl-ACP reductase from Plasmodium falciparum, a key enzyme in fatty acid biosynthesis","volume":"393","author":"Wickramasinghe","year":"2006","journal-title":"Biochem. J."},{"key":"10.1016\/j.biopha.2018.05.009_bib0430","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1107\/S0907444903022327","article-title":"Crystallization and preliminary crystallographic analysis of \u03b2-hydroxy acyl ACP dehydratase (Fab Z) from Plasmodium falciparum","volume":"60","author":"Swarna Mukhi","year":"2004","journal-title":"Acta Crystallogr. Sect. D: Biol. Crystallogr."},{"key":"10.1016\/j.biopha.2018.05.009_bib0435","doi-asserted-by":"crossref","first-page":"45661","DOI":"10.1074\/jbc.M304283200","article-title":"Identification, characterization, and inhibition of Plasmodium falciparum hydroxyacyl-acyl carrier protein dehydratase (FabZ)","volume":"273","author":"Sharma","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2018.05.009_bib0440","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.plipres.2013.06.003","article-title":"Lipid synthesis in protozoan parasites: a comparison between kinetoplastids and apicomplexans","volume":"52","author":"Ramakrishnan","year":"2013","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.biopha.2018.05.009_bib0445","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1021\/jm0600545","article-title":"Inhibition of Plasmodium falciparum fatty acid biosynthesis: evaluation of FabG, FabZ, and FabI as drug targets for flavonoids","volume":"49","author":"Tasdemir","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2018.05.009_bib0450","doi-asserted-by":"crossref","first-page":"7475","DOI":"10.1016\/j.bmc.2010.08.055","article-title":"2-Hexadecynoic acid inhibits plasmodial FAS-II enzymes and arrests erythrocytic and liver stage Plasmodium infections","volume":"18","author":"Tasdemir","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.biopha.2018.05.009_bib0455","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1021\/jm061257w","article-title":"Discovery of a rhodanine class of compounds as inhibitors of Plasmodium falciparum enoyl-acyl carrier protein reductase","volume":"50","author":"Kumar","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2018.05.009_bib0460","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.phymed.2008.02.018","article-title":"Inhibiting enoyl-ACP reductase (FabI) across pathogenic microorganisms by linear sesquiterpene lactones from Anthemis auriculata","volume":"15","author":"Karioti","year":"2008","journal-title":"Phytomedicine"},{"key":"10.1016\/j.biopha.2018.05.009_bib0465","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/iub.306","article-title":"SAR and pharmacophore models for the rhodanine inhibitors of Plasmodium falciparum enoyl-acyl carrier protein reductase","volume":"62","author":"Kumar","year":"2010","journal-title":"IUBMB Life"},{"key":"10.1016\/j.biopha.2018.05.009_bib0470","doi-asserted-by":"crossref","first-page":"20851","DOI":"10.1074\/jbc.M211968200","article-title":"Targeting tuberculosis and malaria through inhibition of enoyl reductase compound activity and structural data","volume":"278","author":"Kuo","year":"2003","journal-title":"J. Biol Chem."},{"key":"10.1016\/j.biopha.2018.05.009_bib0475","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1126\/science.285.5433.1573","article-title":"Inhibitors of the non-mevalonate pathway of isoprenoid biosynthesis as antimalarial drugs","volume":"285","author":"Jomaa","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.biopha.2018.05.009_bib0480","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1042\/BJ20041378","article-title":"Isoprenoid biosynthesis as a target for antibacterial and antiparasitic drugs: phosphonohydroxamic acids as inhibitors of deoxyxylulose phosphate reducto-isomerase","volume":"386","author":"Kuntz","year":"2005","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.biopha.2018.05.009_bib0485","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2174\/1568026023394281","article-title":"Inhibitors of protein farnesyltransferase as novel anticancer agents","author":"Ohkanda","year":"2002","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.biopha.2018.05.009_bib0490","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1126\/science.285.5433.1573","article-title":"Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs","volume":"285","author":"Jochen","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.biopha.2018.05.009_bib0495","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1128\/AAC.46.8.2315-2320.2002","article-title":"Clindamycin as an antimalrial drug; Review of clinical trials","volume":"46","author":"Lell","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2018.05.009_bib0500","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/ardp.200700069","article-title":"Double ester prodrugs of FR900098 display enhanced in-vitro antimalarial activity","volume":"340","author":"Wiesner","year":"2007","journal-title":"Arch. Pharm. Chem. Life Sci."},{"key":"10.1016\/j.biopha.2018.05.009_bib0505","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1021\/jm0491039","article-title":"Protein farnesyltransferase inhibitors exhibit potent antimalarial activity","volume":"48","author":"Bauer","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2018.05.009_bib0510","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1128\/AAC.05012-14","article-title":"In vivo antimalarial activity and mechanism of action of 4-nerolidylcatechol derivatives","volume":"59","author":"Rochae Silva","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2018.05.009_bib0515","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3347\/kjp.2015.53.4.421","article-title":"Effect of farnesyltransferase inhibitor R115777 on mitochondria of Plasmodium falciparum","volume":"53","author":"Ha","year":"2015","journal-title":"Korean J. Parasitol."},{"key":"10.1016\/j.biopha.2018.05.009_bib0520","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2174\/1389557515666150511152433","article-title":"The recent development of Farnesyltransferase inhibitors as anticancer and antimalarial agents","volume":"15","author":"Shen","year":"2015","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.biopha.2018.05.009_bib0525","doi-asserted-by":"crossref","first-page":"21839","DOI":"10.1074\/jbc.272.35.21839","article-title":"Heme biosynthesis by the malarial parasite","volume":"272","author":"Bonday","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2018.05.009_bib0530","doi-asserted-by":"crossref","first-page":"e09143","DOI":"10.7554\/eLife.09143","article-title":"Deconvulting heme biosynthesis to target blood-stage malaria parasites","author":"Sigala","year":"2015","journal-title":"eLife"},{"issue":"6","key":"10.1016\/j.biopha.2018.05.009_bib0535","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/78659","article-title":"Import of host \u03b4-aminolevulinate dehydratase into the malarial parasite: identification of a new drug target","author":"Bonday","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2018.05.009_bib0540","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1042\/bj20020834","article-title":"Involvement of \u03b4-aminolevulinate synthase encoded by the parasite gene in denovo haem Z.Q. synthesis by Plasmodium falciparum","volume":"367","author":"Varadharajan","year":"2002","journal-title":"Biochem. J."},{"key":"10.1016\/j.biopha.2018.05.009_bib0545","doi-asserted-by":"crossref","first-page":"6934","DOI":"10.1074\/jbc.M311409200","article-title":"\u03b4-Aminolevulinic acid dehydratase from Plasmodium falciparum-indigenous vs imported","volume":"279","author":"Dhanasekaran","year":"2004","journal-title":"J. Biol Chem."},{"key":"10.1016\/j.biopha.2018.05.009_bib0550","doi-asserted-by":"crossref","first-page":"34827","DOI":"10.1074\/jbc.M114.615831","article-title":"The heme biosynthesis pathway is essential for P. falciparum development in mosquito stage but not in blood stages","volume":"289","author":"Ke","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2018.05.009_bib0555","doi-asserted-by":"crossref","first-page":"e1003522","DOI":"10.1371\/journal.ppat.1003522","article-title":"Malaria parasite-synthesized heme is essential in the mosquito and liver stages and complements host heme in the blood stages of infection","author":"Nagaraj","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.biopha.2018.05.009_bib0560","series-title":"Antimalarial Chemotherapy: Mechanisms of Action, Resistance and New Directions in Drug Discovery","first-page":"265","article-title":"Antibiotics and the plasmodial plastid organelle","author":"Clough","year":"2001"},{"key":"10.1016\/j.biopha.2018.05.009_bib0565","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1128\/AAC.46.9.2752-2764.2002","article-title":"N-Alkyl urea hydroxamic acids as a new class of peptide deformylase inhibitors with antibacterial activity","volume":"46","author":"Hackbarth","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2018.05.009_bib0570","doi-asserted-by":"crossref","first-page":"4786","DOI":"10.1073\/pnas.88.11.4786","article-title":"Chloroquine inhibits heme-dependent protein synthesis in Plasmodium falciparum","volume":"88","author":"Surolia","year":"1991","journal-title":"PNAS"},{"key":"10.1016\/j.biopha.2018.05.009_bib0575","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1128\/AAC.47.2.735-738.2003","article-title":"Fosmidomycin, a novel chemotherapeutic agent for malaria","volume":"47","author":"Lee","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2018.05.009_bib0580","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1128\/AAC.46.8.2518-2524.2002","article-title":"Assessment of drugs against plasmodium falciparum in vitro","volume":"46","author":"Ohrt","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.biopha.2018.05.009_bib0585","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1006\/jmbi.1996.0449","article-title":"Complete gene map of the plastid-like DNA of the malaria parasite Plasmodium falciparum","volume":"261","author":"Wilson","year":"1996","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.biopha.2018.05.009_bib0590","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/435981","article-title":"Trafficked proteins-druggable in plasmodium falciparum?","author":"Lindner","year":"2013","journal-title":"Int. J. Cell. Biol."},{"issue":"5607","key":"10.1016\/j.biopha.2018.05.009_bib0595","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1126\/science.1078599","article-title":"Dissecting apicoplast targeting in the malaria parasite Plasmodium falciparum","volume":"299","author":"Foth","year":"2003","journal-title":"Science"},{"issue":"21","key":"10.1016\/j.biopha.2018.05.009_bib0600","doi-asserted-by":"crossref","first-page":"12352","DOI":"10.1073\/pnas.95.21.12352","article-title":"Nuclear-encoded proteins target to the plastid in Toxoplasma gondii and Plasmodium falciparum","volume":"95","author":"Waller","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.biopha.2018.05.009_bib0605","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1093\/emboj\/19.8.1794","article-title":"Protein trafficking to the plastid of Plasmodium falciparum is via the secretory pathway","volume":"19","author":"Waller","year":"2000","journal-title":"EMBO J."},{"issue":"1-2","key":"10.1016\/j.biopha.2018.05.009_bib0610","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0167-4889(01)00154-9","article-title":"Translocation of proteins across the multiple membranes of complex plastids","volume":"1541","author":"van Dooren","year":"2001","journal-title":"Biochim. et Biophys. Acta Mol. Cell. Res."},{"issue":"4","key":"10.1016\/j.biopha.2018.05.009_bib0615","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1104\/pp.122.4.1289","article-title":"Identification of a Hsp70 recognition domain within the Rubisco small subunit transit peptide","volume":"122","author":"Ivey","year":"2000","journal-title":"Plant Physiol."},{"issue":"9","key":"10.1016\/j.biopha.2018.05.009_bib0620","doi-asserted-by":"crossref","first-page":"6388","DOI":"10.1074\/jbc.M610251200","article-title":"15-deoxyspergualin primarily targets the trafficking of apicoplast proteins in Plasmodium falciparum","volume":"282","author":"Ramya","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2018.05.009_bib0625","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.bbrc.2006.07.082","article-title":"15-deoxyspergualin modulates Plasmodium falciparum heat shock protein function","volume":"348","author":"Ramya","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2018.05.009_bib0630","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/iub.583","article-title":"15-deoxyspergualin hinders physical interaction between basic residues of transit peptide in PfENR and Hsp70-1","volume":"64","author":"Banerjee","year":"2012","journal-title":"IUBMB Life"},{"issue":"1","key":"10.1016\/j.biopha.2018.05.009_bib0635","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1086\/648594","article-title":"Susceptibility of Plasmodium falciparum isolates to doxycycline is associated with pftetQ sequence polymorphisms and pftetQ and pfmdt copy numbers","volume":"201","author":"Briolant","year":"2010","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.biopha.2018.05.009_bib0640","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.molbiopara.2007.01.005","article-title":"The effects of anti-bacterials on the malaria parasite Plasmodium falciparum","volume":"152","author":"Goodman","year":"2007","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.biopha.2018.05.009_bib0645","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0014-5793(03)00673-2","article-title":"Apicomplexan parasites contain a single lipoic acid synthase located in the plastid","volume":"547","author":"Thomsen-Zieger","year":"2003","journal-title":"FEBS Lett."},{"key":"10.1016\/j.biopha.2018.05.009_bib0650","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1042\/BST0330977","article-title":"Plasmodium falciparum possesses organelle-specific \u03b1-keto acid dehydrogenase complexes and lipoylation pathways","volume":"33","author":"Gunther","year":"2005","journal-title":"Biochem Soc. Trans."},{"key":"10.1016\/j.biopha.2018.05.009_bib0655","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/31723","article-title":"Evidence for the shikimate pathway in apicomplexan parasites","volume":"393","author":"Roberts","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2018.05.009_bib0660","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1128\/AAC.43.1.175","article-title":"Targeting the shikimate pathway in the malaria parasite plasmodium falciparum","volume":"43","author":"McConkey","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2018.05.009_bib0665","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1046\/j.1365-2958.2001.02366.x","article-title":"Subcellular localization and characterization of chorismate synthase in the apicomplexan Plasmodium falciparum","volume":"40","author":"Fitzpatrick","year":"2001","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.biopha.2018.05.009_bib0670","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0166-6851(01)00429-7","article-title":"2 RNA interference (RNAi) inhibits growth of Plasmodium falciparum","volume":"119","author":"McRobert","year":"2002","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.biopha.2018.05.009_bib0675","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1128\/AAC.38.2.403","article-title":"(6S)-6-Fluoroshikimic acid, an antibacterial agent acting on the aromatic biosynthetic pathway","volume":"38","author":"Davies","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2018.05.009_bib0680","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.pt.2003.11.001","article-title":"Annotating the Plasmodium genome and the enigma of the shikimate pathway","volume":"20","author":"McConkey","year":"2004","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.biopha.2018.05.009_bib0685","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/jac\/dkl104","article-title":"The past, present and future of antifolates in the treatment of Plasmodium falciparum infection","volume":"57","author":"Nzila","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"10.1016\/j.biopha.2018.05.009_bib0690","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1039\/b211636g","article-title":"Pyrimethamine analogs as strong inhibitors of double and quadruple mutants of dihydrofolate reductase in human malaria parasites","author":"Sardarian","year":"2003","journal-title":"Org. Biomol. Chem."},{"issue":"54","key":"10.1016\/j.biopha.2018.05.009_bib0695","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.1128\/AAC.49.9.3652-3657.2005","article-title":"2,4-Diaminopteridine- based compounds as precursors for de novo synthesis of antifolates: a novel class of antimalarials","author":"Nduati","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.biopha.2018.05.009_bib0700","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1128\/AAC.36.4.704","article-title":"Molecular target of 5-fluoroorotate in the human malaria parasite, plasmodium falciparum","volume":"36","author":"Rathod","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2018.05.009_bib0705","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ijpara.2016.04.002","article-title":"Identifying antimalairal compounds targeting dihydrofolate reductase-thymidylate synthase (DHFR-TS) by chemogenomic profiling","volume":"46","author":"Aroonsri","year":"2016","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.biopha.2018.05.009_bib0710","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0166-6851(00)00282-6","article-title":"Gene organization of a Plasmodium falciparum serine hydroxymethyltransferase and its functional expression in Escherichia coli","volume":"110","author":"Alfadhli","year":"2000","journal-title":"Mol. Biochem. Parasitol."},{"issue":"115","key":"10.1016\/j.biopha.2018.05.009_bib0715","first-page":"1","article-title":"A three-dimensional structure of Plasmodium falciparum serine hydroxymethyltransferase in complex with glycine and 5-formyltetrahydrofolate","author":"Franca","year":"2005","journal-title":"Homol. Model. Mol. Dynam. Biophys. Chem."},{"issue":"107","key":"10.1016\/j.biopha.2018.05.009_bib0720","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0031182000079348","article-title":"The methionine synthesis cycle and salvage of methyltetrahydrofolate from host red cells in the malaria parasite Plasmodium falciparum","author":"Asawamahasakda","year":"1993","journal-title":"Parasitology"},{"key":"10.1016\/j.biopha.2018.05.009_bib0725","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/BF00931158","article-title":"Characterization of cobalamin-dependent methionine synthase purified from the human malarial parasite Plasmodium falciparum","volume":"75","author":"Krungkrai","year":"1989","journal-title":"Parasitol. Res."},{"issue":"1","key":"10.1016\/j.biopha.2018.05.009_bib0730","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2217\/17460913.1.1.113","article-title":"Folate metabolism as a source of molecular targets for antimalarials","author":"Yuthavong","year":"2006","journal-title":"Fut. Microbiol."},{"key":"10.1016\/j.biopha.2018.05.009_bib0735","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/iub.1047","article-title":"Glucose-6-phosphate metabolism in Plasmodium falciparum","volume":"64","author":"Preuss","year":"2012","journal-title":"IUBMB Life"},{"key":"10.1016\/j.biopha.2018.05.009_bib0740","doi-asserted-by":"crossref","first-page":"31429","DOI":"10.1074\/jbc.M402433200","article-title":"Identification and activity of a series of azolebased compounds with lactate dehydrogenase directed antimalarial activity","volume":"279","author":"Cameron","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.biopha.2018.05.009_bib0745","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1021\/cc060110n","article-title":"Generation of oxamic acid libraries: antimalarials and inhibitors of Plasmodium falciparum lactate dehydrogenase","author":"Choi","year":"2007","journal-title":"J. Comb. Chem."},{"key":"10.1016\/j.biopha.2018.05.009_bib0750","doi-asserted-by":"crossref","first-page":"13178","DOI":"10.1021\/bi025783a","article-title":"Structure of the Plasmodium falciparum triosephosphate isomerase\u2013phosphoglycolate complex in two crystal forms. Characterization of catalytic loop open and closed conformations of the ligand-bound state","volume":"41","author":"Parthasarathy","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.biopha.2018.05.009_bib0755","first-page":"19","article-title":"Aza-acyclic nucleoside phosphonates containing a second phosphonate group as inhibitors of the human, Plasmodium falciparum and vivax 6-oxopurine phosphoribosyltransferases and their prodrugs as antimalarialagents","volume":"1342","author":"Keough","year":"2015","journal-title":"AnnNY Acad. Sci."},{"issue":"12","key":"10.1016\/j.biopha.2018.05.009_bib0760","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1073\/pnas.1416611112","article-title":"Antimalarial 4(1H)-pyridones bind to the Qi site of cytochrome bc1","volume":"112","author":"Capper","year":"2015","journal-title":"PNAS"},{"key":"10.1016\/j.biopha.2018.05.009_bib0765","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.molbiopara.2011.01.002","article-title":"Design of antiparasitic and antifungal hydroxy-naphthoquinones that are less susceptible to drug resistance","volume":"177","author":"Hughes","year":"2011","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.biopha.2018.05.009_bib0770","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.1016\/j.bmcl.2011.07.044","article-title":"Potent antimalarial 4-pyridones with improved physico-chemical properties","volume":"21","author":"Bueno","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2018.05.009_bib0775","doi-asserted-by":"crossref","first-page":"11557","DOI":"10.1021\/ja201729z","article-title":"Glutathione reductase-catalyzed cascade of redox reactions to bioactivate potent antimalarial 1,4-naphthoquinones--a new strategy to combat malarial parasites","volume":"133","author":"Muller","year":"2011","journal-title":"Chem. Soc."},{"key":"10.1016\/j.biopha.2018.05.009_bib0780","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1093\/infdis\/jis184","article-title":"Drug screen targeted at Plasmodium liver stages identifies a potent multistage antimalarial drug","volume":"205","author":"Da Cruz","year":"2012","journal-title":"Infect. Dis."},{"issue":"55","key":"10.1016\/j.biopha.2018.05.009_bib0785","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1021\/jm201179h","article-title":"Identification, design and biological evaluation of bisaryl quinolones targeting plasmodium falciparum type II NADH:quinone oxidoreductase","author":"Pidathala","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2018.05.009_bib0790","doi-asserted-by":"crossref","first-page":"5841","DOI":"10.1021\/jm300157n","article-title":"Factor influencing the specificity of inhibitor binding to the human and malaria parasite dihydroorotate dehydrogenase","volume":"55","author":"Bedingfield","year":"2012","journal-title":"Med. Chem."},{"key":"10.1016\/j.biopha.2018.05.009_bib0795","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1021\/jm501127s","article-title":"Design, synthesis, x-ray crystallographic analysis, and biological evaluation of thiazole derivatives as potent and selective inhibitors of human dihydroorotate dehydrogenase","volume":"58","author":"Zhu","year":"2015","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.biopha.2018.05.009_bib0800","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1021\/acs.jcim.5b00680","article-title":"Identification of new human malaria parasite plasmodium falciparum dihydroorotate dehydrogenase inhibitors by pharmacophore and structure-based virtual screening","volume":"56","author":"Pavadai","year":"2016","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.biopha.2018.05.009_bib0805","doi-asserted-by":"crossref","first-page":"8341","DOI":"10.1021\/jm300630p","article-title":"Discovery of diverse human dihydroorotate dehydrogenase inhibitors as immunosuppressive agents by structure-based virtual screenin","volume":"55","author":"Diao","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2018.05.009_bib0810","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1021\/jm500481t","article-title":"Fluorine modulates species selectivity in the triazolopyrimidine class of P. Falciparum dihydroorotate dehydrogenase inhibitors","volume":"57","author":"Deng","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2018.05.009_bib0815","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.2174\/138955711797247707","article-title":"Recent developments in the medicinal chemistry and therapeutic potential of dihydroorotate dehydrogenase (DHODH) inhibitors","volume":"11","author":"Vyas","year":"2011","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.biopha.2018.05.009_bib0820","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1021\/acs.jmedchem.5b00606","article-title":"Original 2-(3-Alkoxy-1H-pyrazol-1-yl)azines inhibitors of human dihydroorotate dehydrogenase (DHODH)","volume":"58","author":"Hourani","year":"2015","journal-title":"J. Med. Chem."},{"issue":"296","key":"10.1016\/j.biopha.2018.05.009_bib0825","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa6645","article-title":"A long duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria","volume":"157","author":"Phillips","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.biopha.2018.05.009_bib0830","series-title":"DSM265 Phase IIA Investigation Treating Plasmodiumfalciparum or vivax","year":"2018"},{"issue":"7131","key":"10.1016\/j.biopha.2018.05.009_bib0835","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nature05572","article-title":"Specific role of mitochondrial electron transport in blood-stage Plasmodium falciparum","volume":"446","author":"Painter","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2018.05.009_bib0840","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/0169-4758(94)90079-5","article-title":"Coenzyme Q homologs in parasitic protozoa as targets for chemotherapeutic attack","volume":"10","author":"Ellis","year":"1994","journal-title":"Parasitol. Today"},{"key":"10.1016\/j.biopha.2018.05.009_bib0845","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1152\/physrev.2001.81.2.495","article-title":"Membrane transport in the malaria-infected erythrocyte","volume":"81","author":"Kirk","year":"2001","journal-title":"Physiol Rev."},{"key":"10.1016\/j.biopha.2018.05.009_bib0850","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/gb-2005-6-3-r26","article-title":"The\u2019 permeome\u2019 of the malaria parasite: an overview of the membrane transport proteins of plasmodium falciparum","volume":"6","author":"Martin","year":"2005","journal-title":"Genome Biol."},{"issue":"8","key":"10.1016\/j.biopha.2018.05.009_bib0855","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2174\/1386207053328138","article-title":"The new permeability pathways: targets and selective routes for the development of new antimalarial agents","author":"Staines","year":"2005","journal-title":"Comb. Chem. High. Throughput Screen."},{"key":"10.1016\/j.biopha.2018.05.009_bib0860","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.molbiopara.2003.10.009","article-title":"Furosemide analogues as potent inhibitors of the new permeability pathways of Plasmodium falciparum-infected human erythrocytes","volume":"133","author":"Staines","year":"2004","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.biopha.2018.05.009_bib0865","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.pt.2012.08.002","article-title":"PfCRT and its role in antimalarial drug resistance","volume":"28","author":"Ecker","year":"2012","journal-title":"Trends Parasitol."},{"issue":"6","key":"10.1016\/j.biopha.2018.05.009_bib0870","first-page":"861","article-title":"Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance","author":"Fennell","year":"2000","journal-title":"Mol. Cell."},{"key":"10.1016\/j.biopha.2018.05.009_bib0875","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1021\/ml300062q","article-title":"Deciphering the resistance-counteracting functions of ferroquine in Plasmodium falciparum-infected erythrocytes","volume":"3","author":"Dubar","year":"2012","journal-title":"ACS Med. Chem. Lett."},{"issue":"9","key":"10.1016\/j.biopha.2018.05.009_bib0880","doi-asserted-by":"crossref","first-page":"4461","DOI":"10.1128\/AAC.01375-10","article-title":"Ex vivo drug susceptibility of ferroquine against chloroquine-resistant isolates of Plasmodium falciparum and P.vivax","volume":"55","author":"Marfurt","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"10.1016\/j.biopha.2018.05.009_bib0885","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1021\/jm8012757","article-title":"Synthesis, antimalarial activity, and preclinical pharmacology of a novel series of 4\u2019-fluoro and 4\u2019-chloro analogues of amodiaquine. Identification of a suitable \"back-up\" compound for n-tert-butyl isoquine","volume":"52","author":"O\u2019Neill","year":"2009","journal-title":"J. Med. Chem."},{"issue":"19","key":"10.1016\/j.biopha.2018.05.009_bib0890","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1016\/j.febslet.2013.07.052","article-title":"Studies with the plasmodium falciparum hexokinase reveal that PfHT limits the rate of glucose entry into glycolysis","volume":"587","author":"Tjhin","year":"2013","journal-title":"FEBS Lett."},{"issue":"6","key":"10.1016\/j.biopha.2018.05.009_bib0895","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.tmaid.2008.01.005","article-title":"New antimalarial targets: the example of glucose transport","author":"Patel","year":"2008","journal-title":"Travel Med. Infect. Dis."},{"key":"10.1016\/j.biopha.2018.05.009_bib0900","first-page":"0123598","article-title":"Identification of selective inhibitors of the Plasmodium falciparum hexose transporter PfHT by screening focused libraries of Antimalarial compounds","volume":"104","author":"Ortiz","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2018.05.009_bib0905","doi-asserted-by":"crossref","first-page":"6203","DOI":"10.1128\/AAC.00899-15","article-title":"The glucose transporter PfHT1 is an antimalarial target of the HIV protease inhibitor Lopinavir","volume":"59","author":"Kraft","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"issue":"287","key":"10.1016\/j.biopha.2018.05.009_bib0910","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1126\/science.287.5460.1960","article-title":"Drug discovery: a historical perspective","author":"Drews","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.biopha.2018.05.009_bib0915","first-page":"485","article-title":"Aquaporins as targets for drug discovery","volume":"10","author":"Castle","year":"2005","journal-title":"Drug. Discov."},{"key":"10.1016\/j.biopha.2018.05.009_bib0920","doi-asserted-by":"crossref","first-page":"4874","DOI":"10.1074\/jbc.M110683200","article-title":"A single bi-functional aquaglyceroporin in blood-stage Plasmodium falciparum malaria parasites","volume":"277","author":"Hansen","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2018.05.009_bib0925","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.bbamem.2005.12.002","article-title":"Dihydroxyacetone and methylglyoxal as permeants of the Plasmodium aquaglyceroporin inhibit parasite proliferation","volume":"1758","author":"Pavlovic-Djuranovic","year":"2006","journal-title":"Biochem. Biophys. Acta Biomembr."},{"issue":"7","key":"10.1016\/j.biopha.2018.05.009_bib0930","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1073\/pnas.0610843104","article-title":"Aquaglyceroporin PbAQP during intraerythrocytic development of the malaria parasite Plasmodium berghei","volume":"104","author":"Promeneur","year":"2007","journal-title":"PNAS"},{"key":"10.1016\/j.biopha.2018.05.009_bib0935","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1517\/14728220902817839","article-title":"Novel therapeutic targets in Plasmodium falciparum: aquaglyceroporins","volume":"13","author":"Kun","year":"2009","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.biopha.2018.05.009_bib0940","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.1046\/j.1432-1327.2001.02265.x","article-title":"The drug\/metabolite transporter superfamily","volume":"268","author":"Jack","year":"2001","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.biopha.2018.05.009_bib0945","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1042\/bse0500161","article-title":"The P-glycoprotein multidrug transporter","volume":"50","author":"Sharom","year":"2011","journal-title":"Essays Biochem."},{"key":"10.1016\/j.biopha.2018.05.009_bib0950","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0140-6736(04)16767-6","article-title":"Mefloquine resistance in P. falciparum and increased pfmdr1 gene copy number","volume":"364","author":"Price","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2018.05.009_bib0955","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bbrc.2004.06.135","article-title":"Plasmodium falciparum expresses a multidrug resistance-associated protein","volume":"321","author":"Klokouzas","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2018.05.009_bib0960","doi-asserted-by":"crossref","first-page":"10683","DOI":"10.1074\/jbc.275.14.10683","article-title":"Isolation and functional characterization of the PfNT1 nucleoside transporter gene from Plasmodium falciparum","volume":"275","author":"Carter","year":"2000","journal-title":"J. Biol Chem."},{"key":"10.1016\/j.biopha.2018.05.009_bib0965","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1042\/bj3490067","article-title":"Identification of a nucleoside\/nucleobase transporter from Plasmodiumfalciparum, a novel target for antimalarial chemotherapy","volume":"349","author":"Parker","year":"2000","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.biopha.2018.05.009_bib0970","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1042\/BJ20112220","article-title":"Malaria parasite type 4 equilibrative nucleoside transporters (ENT4) are purine transporters with distinct substrate specificity","volume":"446","author":"Frame","year":"2012","journal-title":"Biochem. J."},{"key":"10.1016\/j.biopha.2018.05.009_bib0975","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1042\/BJ20071460","article-title":"A comprehensive model of purine uptake by the malaria parasite Plasmodium falciparum: identification of four purine transport activities in intraerythrocytic parasites","volume":"411","author":"Quashie","year":"2008","journal-title":"Biochem J."},{"key":"10.1016\/j.biopha.2018.05.009_bib0980","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.molbiopara.2008.06.012","article-title":"Genetic evidence for the essential role of PfNT1 in the transport and utilization of xanthine, guanine, guanosine and adenine by Plasmodium falciparum","volume":"161","author":"Bissati","year":"2008","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.biopha.2018.05.009_bib0985","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/nyas.12568","article-title":"Purine import into malaria parasites as a target for antimalarial drug development","volume":"1342","author":"Frame","year":"2015","journal-title":"Ann. N.Y. Acad. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2018.05.009_bib0990","first-page":"1","article-title":"Targeting the Plasmodium vivax equilibrative nucleoside transporter 1 (PvENT1) for antimalarial drug development","volume":"6","author":"Deniskin","year":"2016","journal-title":"Int. J. Parasitol.: Drug.s Drug. Resist."},{"key":"10.1016\/j.biopha.2018.05.009_bib0995","doi-asserted-by":"crossref","first-page":"8840","DOI":"10.1073\/pnas.0601876103","article-title":"Plasmodium falciparum ensures its amino acid supply with multiple acquisition pathways and redundant proteolytic enzyme systems","volume":"103","author":"Liu","year":"2006","journal-title":"PNAS"},{"key":"10.1016\/j.biopha.2018.05.009_bib1000","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0166-6851(01)00427-3","article-title":"Intraerythrocytic Plasmodium falciparum utilizes only a fraction of the amino acids derived from the digestion of host cell cytosol for the biosynthesis of its proteins","volume":"119","author":"Krugliak","year":"2002","journal-title":"Mol. Biochem. Parasitol."},{"issue":"5","key":"10.1016\/j.biopha.2018.05.009_bib1005","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nrm1354","article-title":"Biology, structure and mechanism of P-type ATPases","author":"K\u00fchlbrandt","year":"2004","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"10.1016\/j.biopha.2018.05.009_bib1010","first-page":"149","article-title":"How do p-type ATPases transport ions?","volume":"63","author":"Apell","year":"2004","journal-title":"Bioconjugate Chemistry"},{"key":"10.1016\/j.biopha.2018.05.009_bib1015","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.chom.2012.12.006","article-title":"Na+ regulation in the malaria parasite P. falciparum involves the cation ATPase PfATP4 and is a target of the spiroindolone antimalarials","volume":"13","author":"Spillman","year":"2013","journal-title":"Cell. Host Microbe"},{"key":"10.1016\/j.biopha.2018.05.009_bib1020","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1517\/14728220802600707","article-title":"Regulation of the Na+\/H+ exchanger in the healthy and diseased myocardium","volume":"13","author":"Fliege","year":"2009","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.biopha.2018.05.009_bib1025","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1126\/science.1193225","article-title":"Spiroindolones, a potent compound class for the treatment of malaria","volume":"329","author":"Rottmann","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.biopha.2018.05.009_bib1030","doi-asserted-by":"crossref","first-page":"5521","DOI":"10.1038\/ncomms6521","article-title":"Pyrazoleamide compounds are potent antimalarials that target Na+ homeostasis in intraerythrocytic P. falciparum","volume":"5","author":"Vaidya","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2018.05.009_bib1035","doi-asserted-by":"crossref","first-page":"5455","DOI":"10.1073\/pnas.1414221111","article-title":"A clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance of plasmodium","volume":"111","author":"Jimenez-Diaz","year":"2014","journal-title":"PNAS"},{"key":"10.1016\/j.biopha.2018.05.009_bib1040","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa1315860","article-title":"Spiroindolone KAE609 for falciparum and vivax malaria","volume":"371","author":"Nicholus","year":"2014","journal-title":"N. Eng. J. Med."},{"key":"10.1016\/j.biopha.2018.05.009_bib1045","first-page":"149","article-title":"The malaria parasite cation ATPase PfATP4 and its role in the mechanism of action of a new arsenal of antimalarial drugs","volume":"5","author":"Spillman","year":"2015","journal-title":"Int. J. Parasitol.: Drug.s Drug. Resist."},{"key":"10.1016\/j.biopha.2018.05.009_bib1050","series-title":"Antimalarial Chemotherapy: Mechanisms of Action, Resistance, and New Directions in Drug Discovery","first-page":"347","article-title":"Inhibitors of phospholipid metabolism","author":"Vial","year":"2001"},{"key":"10.1016\/j.biopha.2018.05.009_bib1055","first-page":"1173","article-title":"Pathways for phosphatidylcholine biosynthesis: targets and strategies for antimalarial drugs","author":"Gabriella","year":"2006","journal-title":"Fut. Lipidol."},{"key":"10.1016\/j.biopha.2018.05.009_bib1060","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1182\/blood-2004-03-1084","article-title":"RHughes, characterization of the choline carrier of Plasmodium falciparum: a route for the selective delivery of novel antimalarial drugs","volume":"104","author":"Biagini","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2018.05.009_bib1065","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1128\/AAC.47.8.2590-2597.2003","article-title":"Potential inhibitors of Plasmodium phospholipid metabolism with a broad spectrum of in vitro antimalarial activities","volume":"47","author":"Ancelin","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2018.05.009_bib1070","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1021\/jm9911027","article-title":"Antimalarial activity of compounds interfering with Plasmodium falciparum phospholipid metabolism comparison between mono and bisquaternary ammonium salts","volume":"43","author":"Calas","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2018.05.009_bib1075","doi-asserted-by":"crossref","first-page":"15458","DOI":"10.1073\/pnas.0404037101","article-title":"Prodrugs of bisthiazolium salts are orally potent antimalarials","volume":"101","author":"Vial","year":"2004","journal-title":"PNAS"},{"key":"10.1016\/j.biopha.2018.05.009_bib1080","unstructured":"https:\/\/www.mmv.org\/research-development\/mmv-supported-projects Accessed on 18 February 2018.s."},{"key":"10.1016\/j.biopha.2018.05.009_bib1085","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ijmm.2012.07.007","article-title":"Thioredoxin and glutathione systems in Plasmodium falciparum","volume":"302","author":"Jortzik","year":"2012","journal-title":"Int. J. Med. Microbiol."},{"issue":"1830","key":"10.1016\/j.biopha.2018.05.009_bib1090","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1016\/j.bbagen.2012.09.018","article-title":"Glutathione catalysis and the reaction mechanisms of glutathione-dependent enzymes","author":"Deponte","year":"2013","journal-title":"Biochem. Biophys Acta."},{"issue":"19","key":"10.1016\/j.biopha.2018.05.009_bib1095","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.2174\/1381612811319140003","article-title":"1,4-naphthoquinones and other NADPH-dependent glutathione reductase-catalyzed redox cyclers as antimalarial agents","author":"Belorgey","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.biopha.2018.05.009_bib1100","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.biocel.2015.01.014","article-title":"Targeting the intersubunit cavity of Plasmodium falciparum glutathione reductase by a novel natural inhibitor: computational and experimental evidence","volume":"61","author":"Tyagi","year":"2015","journal-title":"Int. J. Biochem. Cell. Biol."},{"key":"10.1016\/j.biopha.2018.05.009_bib1105","doi-asserted-by":"crossref","first-page":"7262","DOI":"10.1021\/jm300833h","volume":"55","author":"Preuss","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2018.05.009_bib1110","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s001090050253","article-title":"Glucose-6-phosphate dehydrogenase deficiency and malaria","volume":"76","author":"Ruwende","year":"1998","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.biopha.2018.05.009_bib1115","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/hdy.2011.90","article-title":"G6PD deficiency and malaria selection","volume":"108","author":"Luzzatto","year":"2012","journal-title":"Heredity (Edinb.)"},{"issue":"10","key":"10.1016\/j.biopha.2018.05.009_bib1120","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.ijpara.2012.07.005","article-title":"Polyamine uptake by the intraerythrocytic malaria parasite Plasmodium falciparum","volume":"42","author":"Niemand","year":"2012","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.biopha.2018.05.009_bib1125","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.4155\/fmc.12.183","article-title":"Plasmodium kinases as targets for new-generation antimalarials","volume":"4","author":"Lucet","year":"2012","journal-title":"Fut. Med. Chem."},{"key":"10.1016\/j.biopha.2018.05.009_bib1130","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1002\/cbic.201400025","article-title":"Chemical interrogation of the malaria kinome","volume":"15","author":"Derbyshire","year":"2014","journal-title":"Chembiochem."},{"key":"10.1016\/j.biopha.2018.05.009_bib1135","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/infdis\/jit522","article-title":"A specific inhibitor of PfCDPK4 blocks malaria transmission: chemical-genetic validation","volume":"209","author":"Ojo","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.biopha.2018.05.009_bib1140","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1021\/jm500342d","article-title":"Optimization of an imidazopyridazine series of inhibitors of Plasmodium falciparum calcium-dependent protein kinase 1 (PfCDPK1)","volume":"57","author":"Chapman","year":"2014","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.biopha.2018.05.009_bib1145","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1128\/AAC.02220-13","article-title":"Inhibition of protein synthesis and malaria parsite development by drug targeting of methionyl-tRNA synthestase","volume":"59","author":"Hussain","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2018.05.009_bib1150","series-title":"Antimalarial Chemotherapy: Mechanisms of Action, Resistance, and New Directions in Drug Discovery","article-title":"Antibiotics and the plasmodial plastid organelle","author":"Clough","year":"2001"},{"issue":"6","key":"10.1016\/j.biopha.2018.05.009_bib1155","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.pt.2008.03.007","article-title":"Apicoplast translation, transcription and genome replication: targets for antimalarial antibiotics","volume":"24","author":"Dahl","year":"2008","journal-title":"Trends Parasitol.."},{"key":"10.1016\/j.biopha.2018.05.009_bib1160","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1186\/s12936-016-1613-y","article-title":"Antibiotics in malaria therapy: which antibiotics except tetracyclines and macrolides may be used against malaria?","volume":"15","author":"Gaillard","year":"2016","journal-title":"Malar. J."},{"key":"10.1016\/j.biopha.2018.05.009_bib1165","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.chom.2012.04.015","article-title":"Selective and specific inhibition of the plasmodium falciparum lysyl-tRNA synthetase by the fungal secondary metabolite cladosporin","volume":"11","author":"Hoepfner","year":"2012","journal-title":"Cell. Host Microbe."},{"key":"10.1016\/j.biopha.2018.05.009_bib1170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpddr.2013.10.001","article-title":"Aminoacyl-tRNA synthetases as drug target in eukaryotic parasites","volume":"4","author":"Pham","year":"2014","journal-title":"Int. J. Parasitol. Drug. Drug. Resist."},{"key":"10.1016\/j.biopha.2018.05.009_bib1175","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/cr.2010.88","article-title":"Metamorphosis of the malaria parasite in the liver is associated with organelle clearance","volume":"20","author":"Jayabalasingham","year":"2010","journal-title":"Cell. Res."},{"key":"10.1016\/j.biopha.2018.05.009_bib1180","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.molbiopara.2011.02.003","article-title":"Autophagy in parasitic protists: unique features and drug targets","volume":"177","author":"Ana","year":"2011","journal-title":"Mol. Biochem. Parasitol."},{"issue":"11","key":"10.1016\/j.biopha.2018.05.009_bib1185","first-page":"80","article-title":"The multifunctional autophagy pathway in the human malaria parasite, Plasmodium falciparum","volume":"269","author":"Cervantes","year":"2014","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.biopha.2018.05.009_bib1190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0113220","article-title":"Characterization of the autophagy marker protein Atg8 reveals atypical features of autophagy in Plasmodium falciparum","volume":"9","author":"Navale","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.biopha.2018.05.009_bib1195","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.molbiopara.2005.08.020","article-title":"Cellular and molecular actions of dinitroaniline and phosphorothioamidate herbicides on Plasmodium falciparum: tubulin as a specific antimalarial target","volume":"145","author":"Fennell","year":"2006","journal-title":"Mol. Biochem. Parasitol"},{"key":"10.1016\/j.biopha.2018.05.009_bib1200","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.molbiopara.2005.08.020","article-title":"Molecular actions of dinitroaniline and phosphorothioamidate herbicides on P. falciparum: Tubulin as a specific antimalarial target","volume":"145","author":"Brian","year":"2006","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.biopha.2018.05.009_bib1205","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.molbiopara.2013.03.001","article-title":"Antimitotic herbicides bind to an unidentified site on malarial parasite tubulin and block development of liver-stage Plasmodium parasites","volume":"188","author":"Dempsey","year":"2013","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.biopha.2018.05.009_bib1210","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1073\/pnas.1112037108","article-title":"Quantitative assessment of P. falciparum sexual development reveals potent transmission-blocking activity by methylene blue","volume":"108","author":"Adjalley","year":"2011","journal-title":"PNAS"},{"key":"10.1016\/j.biopha.2018.05.009_bib1215","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa1315860","article-title":"Spiroindolone KAE609 for falciparum and vivax malaria","volume":"37","author":"White","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.biopha.2018.05.009_bib1220","doi-asserted-by":"crossref","first-page":"5135","DOI":"10.1128\/AAC.04332-14","article-title":"Salinomycin and other ionophores as a new class of antimalarial drugs with transmission-blocking activity","volume":"9","author":"D\u2019Alessandro","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2018.05.009_bib1225","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1128\/AAC.06377-11","article-title":"The spiroindolone drug candidate NITD609 potently inhibits gametocytogenesis and blocks Plasmodium falciparum transmission to anopheles mosquito vector","volume":"56","author":"Van Pelt-Koops","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2018.05.009_bib1230","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1128\/AAC.01096-10","article-title":"Theostrepton and derivatives exhibit antimalarial and gametocytocidal activity by dually targeting parasite proteasome and apicoplast","volume":"55","author":"Aminake","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2018.05.009_bib1235","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1172\/JCI61822","article-title":"Transmission of malaria to mosquitoes blocked by bumped kinase inhibitors","volume":"122","author":"Ojo","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2018.05.009_bib1240","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1128\/AAC.00920-12","article-title":"A class of tricyclic compounds blocking malaria parasite oocyte development and transmission","volume":"57","author":"Eastman","year":"2013","journal-title":"Antimicrobi. Agents Chemother."},{"key":"10.1016\/j.biopha.2018.05.009_bib1245","series-title":"10 Facts on Malaria","author":"World Health Organization","year":"2018"},{"key":"10.1016\/j.biopha.2018.05.009_bib1250","series-title":"Medicine for Malaria Venture","year":"2018"},{"key":"10.1016\/j.biopha.2018.05.009_bib1255","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s40249-016-0196-8","article-title":"Alternatives to currently used antimalarial drugs: in search of a magic bullet","volume":"5","author":"Bhagavathula","year":"2016","journal-title":"Infect. Dis. Poverty\\."},{"issue":"387","key":"10.1016\/j.biopha.2018.05.009_bib1260","doi-asserted-by":"crossref","first-page":"eaad9735","DOI":"10.1126\/scitranslmed.aad9735","article-title":"Antimalarial efficacy of MMV390048, an inhibitor of Plasmodium phosphatidylinositol 4-kinase","volume":"9","author":"Paquet","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"9","key":"10.1016\/j.biopha.2018.05.009_bib1265","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1128\/AAC.02727-13","article-title":"KAF156 is an antimalarial clinical candidate with potential for use in prophylaxis, treatment and prevention of disease transmission","volume":"58","author":"Kuhen","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"issue":"15","key":"10.1016\/j.biopha.2018.05.009_bib1270","doi-asserted-by":"crossref","first-page":"5540","DOI":"10.1021\/jm200592f","article-title":"Structure-guided lead optimization of triazolopyrimidine-ring substituents identified potent Plasmodium falciparum dihydroorotate dehydrogenase inhibitor with clinical candidate potential","volume":"54","author":"Corteron","year":"2011","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2018.05.009_bib1275","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1021\/jm901473s","article-title":"The structure-activity relationship of the antimalarial ozonide arterolane (OZ277)","volume":"53","author":"Dong","year":"2010","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.biopha.2018.05.009_bib1280","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1093\/jac\/dkl563","article-title":"Antimalarial efficacy and drug interactions of the novel semi-synthetic endoperoxide artemisone in vitro and in vivo","volume":"59","author":"Vivas","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"issue":"2","key":"10.1016\/j.biopha.2018.05.009_bib1285","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1128\/AAC.47.2.735-738.2003","article-title":"Fosmidomycin, a novel chemotherapeutic agent for malaria","volume":"47","author":"Lee","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"10.1016\/j.biopha.2018.05.009_bib1290","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/infdis\/jiu540","article-title":"Efficacy and safety of triple combination therapy with artesunate-amodiaquine-methylene blue for falciparum malaria in children: a randomised controlled trial in Burkina Faso","volume":"211","author":"Coulibaly","year":"2015","journal-title":"J. Infect. Dis."},{"issue":"17","key":"10.1016\/j.biopha.2018.05.009_bib1295","first-page":"1","article-title":"Origin of the specificity of inhibitor P218 towards wild-type and mutant PfDHFR: a molecular dynamics analysis","author":"Abbas","year":"2014","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"2","key":"10.1016\/j.biopha.2018.05.009_bib1300","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00709-014-0697-x","article-title":"New insight-guided approaches to detect, cure","volume":"252","author":"Kumar","year":"2015","journal-title":"Prev. Eliminate Malar. Protoplasma"},{"key":"10.1016\/j.biopha.2018.05.009_bib1305","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01183-15","article-title":"ELQ-300 prodrug for enhanced development and single dose cure of malaria","author":"Miley","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.biopha.2018.05.009_bib1310","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/jac\/dkt486","article-title":"Rapid kill of malaria parasites by artemisin and semi-synthetic endoperoxides involves ROS-dependent polorization of the membrane potential","volume":"69","author":"Antoine","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.biopha.2018.05.009_bib1315","doi-asserted-by":"crossref","first-page":"e26916","DOI":"10.1371\/journal.pone.0026916","article-title":"Plasmodium falciparum parasites are killed by a transition state analogue of purine nucleoside phosphorylase in primate animal model","volume":"1","author":"Cassera","year":"2011","journal-title":"PloS One"},{"issue":"5","key":"10.1016\/j.biopha.2018.05.009_bib1320","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/ja.2012.123","article-title":"Isolation and synthesis of falcitidin, a novel myxobacterial-derived acylretrapeptide with activity against the malaria target falcipain-2","volume":"66","author":"Somanadhan","year":"2013","journal-title":"J. Antibiot. (Tokyo)"},{"issue":"18","key":"10.1016\/j.biopha.2018.05.009_bib1325","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.4155\/fmc.12.177","article-title":"Exploration of 4(1H)-pyridones as a novel family of potent antimalarial inhibitors of the plasmodial cytochromebc1","volume":"4","author":"Bueno","year":"2012","journal-title":"Fut. Med. Chem."},{"issue":"4","key":"10.1016\/j.biopha.2018.05.009_bib1330","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1021\/ml4004952","article-title":"Plasmepsin inhibitory activity and structure-guided optimization of a potent hydroxyethylamine-based antimalarial hit","volume":"5","author":"Jaudzems","year":"2014","journal-title":"ACS Med. Chem. Lett.."},{"key":"10.1016\/j.biopha.2018.05.009_bib1335","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1128\/AAC.01714-10","article-title":"Aminoindoles, a novel scaffold with potent activity against Plasmodium falciparum","volume":"55","author":"Barker Jr","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.biopha.2018.05.009_bib1340","doi-asserted-by":"crossref","first-page":"33054","DOI":"10.1074\/jbc.M110.162081","article-title":"Novel inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase with anti-malarial activity in the mouse model","volume":"285","author":"Booker","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2018.05.009_bib1345","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.1002\/anie.201001026","article-title":"Identification of a 1,2,4,5-tetraoxane antimalarial drug-development candidate (RKA 182) with superior properties to the semisynthetic artemisinins","volume":"49","author":"O\u2019Neill","year":"2010","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.biopha.2018.05.009_bib1350","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nature14451","article-title":"A novel multiple-stage antimalarial agent that inhibit protein synthesis","volume":"522","author":"Baragana","year":"2015","journal-title":"Nature"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218318584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218318584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T11:24:30Z","timestamp":1760095470000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332218318584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":270,"alternative-id":["S0753332218318584"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.05.009","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug targets for resistant malaria: Historic to future perspectives","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}